Filter
16078
Filtered Results: 16078
Text search:
health
for
all
Featured
Recommendations
1342
New Publications
3921
Language
Document type
No document type
8777
Studies & Reports
2631
Guidelines
1858
Manuals
752
Fact sheets
614
Strategic & Response Plan
473
Training Material
316
Situation Updates
213
Infographics
139
Resource Platforms
103
Brochures
85
Online Courses
74
Videos
34
Dashboards/Maps
5
App
4
Countries / Regions
India
659
Global
622
Kenya
408
Sierra Leone
328
South Africa
321
Ethiopia
306
Liberia
299
Nigeria
284
Uganda
278
Nepal
274
Western and Central Europe
253
Latin America and the Carribbean
230
Myanmar / Burma
225
Africa
225
Rwanda
219
Bangladesh
205
Congo, Democratic Republic of
201
Syria
198
Malawi
195
Zambia
193
Germany
189
Tanzania
180
Ukraine
167
Ghana
164
Senegal
153
Philippines
124
Burkina Faso
120
Namibia
114
Indonesia
113
Mozambique
113
Guinea
112
South Sudan
111
Haiti
110
Brazil
107
West and Central Africa
106
Zimbabwe
101
Russia
100
Lesotho
93
Eastern Europe
93
Cambodia
91
Venezuela
90
Yemen
87
East and Southern Africa
87
Middle East and North Africa
83
South–East Asia Region
83
Asia
71
Cameroon
68
Benin
65
Colombia
59
Botswana
59
Mali
51
Afghanistan
48
Eastern Europe and Central Asia
48
Pakistan
45
Eswatini/ Swaziland
43
Central African Republic
41
Côte d’Ivoire / Ivory Coast
40
Madagascar
38
Lebanon
37
Paraguay
37
Somalia
35
Sudan
34
Jordan
32
Peru
32
Vietnam
31
USA
30
Argentina
28
Western Pacific Region
27
Niger
26
Thailand
26
Iraq
24
China
24
Angola
24
Chile
22
Tajikistan
22
Ecuador
20
Togo
19
Turkey
19
Moldova
18
Sri Lanka
17
Albania
17
Guinea-Bissau
16
Chad
16
Laos
15
North America
15
Bolivia
14
Palestine
14
Georgia
14
Spain
13
Papua New Guinea
12
Burundi
12
Libya
12
Mexico
12
Italy
11
Iran
11
Kazakhstan
11
United Kingdom
11
Egypt
10
Southern Africa
10
Portugal
10
North Macedonia
9
Greece
9
Kyrgyzstan
8
Gambia
7
Singapore
7
Switzerland
7
El Salvador
7
Bhutan
7
Poland
7
Armenia
7
Timor Leste/ East Timor
7
Romania
7
Jamaica
7
Saudi Arabia
6
Malaysia
6
Serbia
6
Hungary
6
Morocco
5
Ireland
5
Honduras
5
Guatemala
5
Turkmenistan
5
France
5
Dominican Republic
4
Fiji
4
Congo-Brazzaville
4
Canada
4
Uzbekistan
4
Japan
4
Tunisia
4
Vanuatu
3
Croatia
3
Nicaragua
3
Djibouti
3
Mongolia
3
Estonia
3
Australia
3
Gabon
3
Mauritius
3
Azerbaijan
3
Belarus
3
Bosnia and Herzegovina
3
Mauritania
2
Austria
2
Other region
2
Solomon Islands
2
North Korea
2
Qatar
2
Bulgaria
2
Lithuania
2
Slovakia
2
South Korea
2
French Guyana
2
Israel
2
Cuba
1
Cape Verde
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
Algeria
1
Morocco
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
5930
Clinical Guidelines
1059
Women & Child Health
787
Public Health
749
Key Resources
669
Capacity Building
361
Pharmacy & Technologies
151
Annual Report MEDBOX
3
Toolboxes
COVID-19
1822
Mental Health
1271
HIV
1048
TB
728
Disability
619
Planetary Health
595
Ebola
574
Caregiver
464
Conflict
459
Refugee
438
Rapid Response
431
AMR
401
NTDs
355
NCDs
316
Global Health Education
278
Pharmacy
257
Natural Hazards
225
Health Financing Toolbox
165
Zika
128
Cholera
122
Polio
90
Specific Hazards
89
Social Ethics
81
Typhoon
11
Health Financing
3
South Sudan
2
This collection of posters are intended for health care workers, biomedical engineers and staff of health facilities in charge of caring, cleaning,...
Lancet Planet Health 2021; 5: e542–52
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be devel...
Safe sanitation is essential for health, from preventing infections to improving and maintaining mental and social
well-being. Lack of adequate sanitation contributes to diarrhoeal diseases, parasi...
Zika virus infection: update on the evidence for a causal link to congenital brain abnormalities and Guillain-Barré syndrome
Update 7 September 2016
The clinical guidelines and protocols for the practice of emergency medicine presented in this document are designed to be a useful resource not only for those wishing to become emergency medicine s...
This field guide is a practical tool for improving and maintaining drinking-water safety. It is designed to be used by YOU as a rural community member who shares responsibility for operation and man...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regi...
The National AIDS Control Council (NACC) continues to strengthen partnerships with all stakeholders in the response to HIV and AIDS in Kenya. While recognizing that there is no single preventive approach to reverse the spread of HIV, the f...
he Western Pacific is the world’s most disaster-prone region. When a disaster occurs, people may need to seek accommodation in a disaster evacuation shelter. However, it may be difficult for people in a disaster evacuation shelter to avoid confine...
WHO issued an updated appeal (May 2022) detailing its resource needs for Ukraine and refugee-receiving and hosting countries for March-August for U...
A practical tool for field based humanitarian workers. It provides up-to-date, clear and succint guidance on topics accross the humanitarian sector including references to current, relevant resources and practical tools.
One health Response to AMR Containment.
In a significant move for the public health sector, Kerala has become the first state in India to launch a...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decon...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme <... International Drug Monitoring (PIDM) and other partners, which was held on 20 October 2022.
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates ... hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited inf...
This handbook is for health care providers involved in the care of girls and women who have been subjected to any form of female genital mutilation (FGM). This includes obstetricians and gynaecologi...
Overview
Learning objectives
• Promote respect and dignity for children and adolescents with mental and behavioural
disorders.
• Know common presentations of children and adolescents with mental and behavioural
disorders.
• Know assessme...
This recommendation is an update of one of the 49 recommendations that were published in the WHO recommendations on antenatal care for a positive pregnancy experience. The recommendation was developed initially using the standardized operating proce...
